GTS Securities LLC Trims Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

GTS Securities LLC lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 70.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,806 shares of the medical equipment provider's stock after selling 4,379 shares during the quarter. GTS Securities LLC's holdings in Intuitive Surgical were worth $943,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Norges Bank purchased a new stake in Intuitive Surgical in the fourth quarter worth about $2,401,493,000. Proficio Capital Partners LLC increased its position in Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock worth $495,845,000 after buying an additional 948,902 shares in the last quarter. Capital Research Global Investors increased its position in Intuitive Surgical by 25.5% in the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock worth $1,764,904,000 after buying an additional 687,906 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in Intuitive Surgical in the fourth quarter worth about $313,769,000. Finally, Northern Trust Corp increased its position in Intuitive Surgical by 15.8% in the fourth quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock worth $1,889,126,000 after buying an additional 494,496 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have commented on ISRG. Piper Sandler reduced their price target on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. Robert W. Baird dropped their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Evercore ISI dropped their price objective on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a "buy" rating in a research note on Monday, April 14th. Finally, Royal Bank of Canada dropped their price objective on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus price target of $596.05.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the firm's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This trade represents a 68.85% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the firm's stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the transaction, the executive vice president now owns 5,758 shares in the company, valued at $2,793,033.06. The trade was a 60.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 32,700 shares of company stock valued at $16,865,621. Insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG traded up $2.22 during trading on Wednesday, hitting $552.41. The stock had a trading volume of 1,009,584 shares, compared to its average volume of 1,645,419. Intuitive Surgical, Inc. has a one year low of $396.15 and a one year high of $616.00. The stock has a 50 day simple moving average of $513.67 and a 200 day simple moving average of $538.20. The stock has a market capitalization of $197.99 billion, a price-to-earnings ratio of 86.18, a P/E/G ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same period last year, the company earned $1.50 EPS. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.